Mark Sabag

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TEVA

Current role

Board Member

2013-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, International Markets Commercial	$688,147	$0	$1,999,990	$0	$774,323	$266,674	$3,729,134
2022	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, International Markets Commercial	$744,787	$0	$1,999,995	$0	$899,554	$279,597	$3,923,933
2021	Teva Pharmaceutical Industries Ltd (TEVA)	Executive Vice President, International Markets Commercial	$765,294	$0	$1,999,991	$0	$732,686	$290,770	$3,788,741

No earnings-call appearances or filed executive changes recorded yet.